Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
JYHB2100112	糠酸氟替卡松维兰特罗吸入粉雾剂（Ⅱ）	fluticasone furoate;vilanterol	Powder for inhalation	Chemical Drugs(5.1)	Supplementary Application	2021-02-03	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;Glaxo Group Ltd	In Review	2021-02-03	view
JYHB2100014	糠酸氟替卡松维兰特罗吸入粉雾剂（Ⅱ）	fluticasone furoate;vilanterol	Powder for inhalation	Chemical Drugs(5.1)	Supplementary Application	2021-01-08	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd;Glaxo Operations UK Ltd;GlaxoSmithKline (Ireland) Ltd	Certificate Issued	2021-02-01	view
JYHB1900018	糠酸氟替卡松维兰特罗吸入粉雾剂（Ⅱ）	fluticasone furoate;vilanterol	Powder for inhalation	Chemical Drugs(5.1)	Supplementary Application	2019-01-09		Glaxo Operations UK Ltd;Glaxo Group Ltd	Filed	2019-01-11	view
JXHL1800031	糠酸氟替卡松维兰特罗吸入粉雾剂（Ⅱ）	fluticasone furoate;vilanterol	Powder for inhalation	Chemical Drugs(2.4)	Import Drug Application	2018-02-11	葛兰素史克（中国）投资有限公司	GlaxoSmithKline (China) Investment Co Ltd;Glaxo Group Ltd	Certificate Issued	2018-06-15	view